SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-087325
Filing Date
2022-03-29
Accepted
2022-03-29 06:11:31
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d338679ds3.htm S-3 378429
2 EX-1.1 d338679dex11.htm EX-1.1 189122
3 EX-4.3 d338679dex43.htm EX-4.3 301323
4 EX-5.1 d338679dex51.htm EX-5.1 29793
5 EX-23.2 d338679dex232.htm EX-23.2 1635
6 EX-FILING FEES d338679dexfilingfees.htm EX-FILING FEES 48125
7 GRAPHIC g338679g0326132854791.jpg GRAPHIC 2830
8 GRAPHIC g338679g0326152114691.jpg GRAPHIC 1769
9 GRAPHIC g338679g04a96.jpg GRAPHIC 593583
10 GRAPHIC g338679g33b75.jpg GRAPHIC 597668
11 GRAPHIC g338679g50c11.jpg GRAPHIC 598602
  Complete submission text file 0001193125-22-087325.txt   3397500
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263925 | Film No.: 22777309
SIC: 2836 Biological Products, (No Diagnostic Substances)